CLASS 2 RECALL - SANDIMMUN ORAL SOLUTION

Class 2 Recall -  Sandimmun Oral Solution

Novartis Pharmaceuticals UK are recalling the above batch due to the presence of crystals in the solution. The crystals have been identified as the active substance (ciclosporin). The presence of crystals has been observed in some finished product packs marketed in other countries that share the same master batch as the UK batch above. Therefore, this UK batch is recalled as a precautionary measure. Novartis Pharmaceuticals UK have confirmed no other batches of the product are impacted.

MHRA drug alert date: 20 September 2022

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-novartis-pharmaceuticals-uk-sandimmun-oral-solution-el-22-a-slash-40?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=8bfa30ef-b0bd-4cf8-8ca4-e989982960bf&utm_content=immediately

Alliance do not stock the above products so we will not be accepting Customer returns on this recall.

Further Information For more information, medical or supply enquiries. 

Please contact 01276 698370, or email medinfo.uk@novartis.com